FDA Approves First Dermal Filler for Acne Scars

The U.S. Food and Drug Administration approved the first dermal filler to treat scarring caused by acne, the most common skin disorder in the United States afflicting 40-50 million people.
Many plastic surgeons and dermatologists have used other fillers, off label, to help fill acne scars, including ice-pick, pitted, atrophic scars (flat, thin, or depressed), and hypertropic or keloid scars, those that are thick or lumpy. 
While many of us experience the slow actualization of our mortality through those wrinkles we often see as scars from living life, imagine how a young, vibrant person feels going through the onslaught of pain from not only from the appearance of nodular acne but also the resulting scars. My brother experienced this, and I can share that it affected his entire being. My parents had him put on Accutane, but it was too late to avoid the scarring. 
Bellafill, developed by privately held Suneva Medical Inc, has been developed to treat moderate to severe acne scars on the cheeks of patients over the age of 21.
A cure for acne has long eluded drug developers. And from topical gels to lasers, nothing so far has satisfactorily treated scarring that affects up to 95% of acne sufferers.
The U.S. Food and Drug Administration cleared a laser treatment for acne scarring in July, but adoption for this kind of therapy is limited by its high cost, associated pain, and the need for repeat treatments.

No comments:

Post a Comment